21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal
#15902BONE TARGETING OF DEGRADABLE DRUG FILLED NANOPARTICLES
#15903KITS FOR DHEA AND DHEA-SULFATE FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#15904Opioid agonist/antagonist combinations
#15905Vaccine
#15906Preparation for preventing or treating calcium deficiency conditions in mammals
#15907Composition for improving membrane composition and functioning of cells
#15908TREATMENT WITH ANTI-VEGF ANTIBODIES
#15909TREATMENT WITH ANTI-VEGF ANTIBODIES
#15910KINESIN INHIBITORS
#15911Measurement of soluble Tweak levels for evaluation of lupus patients
#15912PRLR-specific antibody and uses thereof
#15913Food Supplement Based on Group B Vitamins, Trace Elements and -3 and/or 6- Fatty Acids and Use of This Food Supplement in the Simultaneous Treatment of Localized Cellulite and Slackening of the Skin
#15914COMPOSITION CONTAINING SEVERAL BOTULIC TOXINS
#15915NOVEL METHODS OF TREATMENT AND DELIVERY MODES
#15916Use of Arginase in Combination with 5FU and Other Compounds for Treatment of Human Malignancies
#15917Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease
#15918Umbilical Cord Stem Cell Composition & Method of Treating Neurological Diseases
#15919Oncolytic Adenovirus Armed with Therapeutic Genes
#159201-METHYL-BENZO[1,2,4]THIADIAZINE 1-OXIDE DERIVATIVES
#15921OXIMYL DIPEPTIDE HEPATITIS C PROTEASE INHIBITORS
#15922METAXALONE PRODUCTS, METHOD OF MANUFACTURE, AND METHOD OF USE
#15923Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione follow by autologous stem cell transplantation
#15924Medicaments For Inhalation Comprising Pde IV Inhibitors and Enantiomerically Pure Glycopyrrolate Salts
#15925SILICONE IN GLYCOL PHARMACEUTICAL AND COSMETIC COMPOSITIONS WITH ACCOMMODATING AGENT
#15926Method of treating with interferons
#15927Photochromic material comprising a proteorhodopsin apoprotein and a retinal analog
#15928Device and method for treatment of wounds with nitric oxide
#15929Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
#15930METHODS AND MATERIALS FOR CONTROLLING RODENT POPULATIONS
#15931CRYSTAL STRUCTURES OF SGLT2 INHIBITORS AND PROCESSES FOR PREPARING SAME
#15932Therapeutic methods and compositions involving isoflavones
#15933Topical compositions containing metronidazole
#15934Topical compositions containing metronidazole
#15935Topical compositions containing metronidazole
#15936Prokinetic agent for bowel preparation
#15937Therapeutic Combination Comprising a Nmda Receptors Blocker and a Narcotic Analgesic Substance
#15938ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS
#15939Presentation of an antiviral pharmaceutical composition
#15940AZA-TRIPEPTIDE HEPATITIS C SERINE PROTEASE INHIBITORS
#15941Dissolution of Arterial Cholesterol Plaques by Pharmacologically Induced Elevation of Endogenous Bile Salts
#15942Use of azapaullones for preventing and treating pancreatic autoimmune disorders
#15943Compositions and methods for treating medical conditions
#15944USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM IN THE PREVENTION OF CARDIOVASCULAR EVENTS
#15945Low Dosage Forms Of Risedronate Or Its Salts
#15946External Skin Composition
#15947Cell fusion promoter and utilization of the same
#15948Pyrazolidinol compounds
#15949Nucleoside analogs in combination therapy of herpes simplex infections
#15950Compositions and Methods for Viscosupplementation
#15951Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus
#15952Method for proliferating natural killer cells
#15953Conjugate Comprising P21 Protein for the Treatment of Cancer
#15954Herbal extract having anti-virus activity and preparation of same
#15955Drink Comprising a Combination of Fish Oil and Probiotics
#15956NOVEL HERBAL FORMULATION AS BRAIN TONIC
#15957Body Fat-Reducing Agent
#15958Skin care composition
#15959Pharmaceutical Composition and Non Dependence Coffee Comprising Edible Carboxylic Acid and/or Its Acid Salts and Coffeine
#15960Topical Wound Care Product Containing Hyssop
#15961Anti-tumor drug, medicament, composition, and use thereof
#15962Pharmaceutical Compositions for the Treatment of Inflammatory and Obstructive Airways Diseases
#15963Low Dosage Forms Of Risedronate Or Its Salts
#15964Wake up on time dietary supplement and method of use
#15965COMPOSITION AND THERAPIES FOR HYPERLIPIDAEMIA-ASSOCIATED DISORDERS
#15966METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS
#15967Methods and devices for the sustained release of multiple drugs
#15968Polymer no donor predrug nanofiber coating for medical devices and therapy
#15969Methionine Enkephalin as an Adjuvant for Vaccine Immunizations
#15970Treatment of diabetes
#15971Anti-CD14 antibody fusion protein
#15972Use of B Cell Expansion Agents in Generating Antibodies
#15973Novel Use of Sulfonamide Compound in Combination with Angiogenesis Inhibitor
#15974Bifeprunox mesylate maintenance dose compositions and methods for using the same
#15975Composition comprising licorice polyphenol
#15976Compositions and Methods for the Enhancement of Chemotherapy with Microbial Cytotoxins
#15977AUGMENTATION AND REPAIR OF SPINCTER DEFECTS WITH CELLS INCLUDING MESENCHYMAL CELLS
#15978COMBINED TUMOR SUPPRESSOR GENE THERAPY AND CHEMOTHERAPY IN THE TREATMENT OF NEOPLASMS
#15979Systemic Treatment of Metastatic and/or Systemically-Disseminated Cancers using GM-CSF-Expressing Poxviruses
#15980Method for treating demyelinating diseases
#15981PIPERIZINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS
#15982Methods for treating sarcoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6 dioxo(3-piperidyl))-isoindoline-1,3-dione
#15983Use of Il-17F for the Treatment and/or Prevention of Neurologic Diseases
#15984Compositions Having a High Antiviral and Antibacterial Efficacy
#15985Using mucin glycoproteins in combination with therapeutic agents to treat epithelial lesions and disorders of impaired mucin function
#15986Therapeutic Skin Treatment Composition and Method
#15987Devices and methodologies useful in body aesthetics
#15988HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDE
#15989Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors
#15990Treatment and prevention of bone loss using resolvins
#15991Methods of preventing the serotonin syndrome and compositions for use thereof
#15992METHODS OF USING [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR TREATING INFECTIOUS DISEASES
#15993Combination of Organic Compounds
#15994COMPOSITIONS AND METHODS FOR TREATING VASCULAR, AUTOIMMUNE, AND INFLAMMATORY DISEASES
#15995COMBINATION THERAPY WITH PARP INHIBITORS
#15996COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#15997Method of Female Contraception and a Kit For Use Therein
#15998Composition containing fermentable polysaccharides
#15999Methods and Compositions for Treating Flaviviruses, Pestiviruses and Hepacivirus
#16000Synergic Combinations Comprising a Quinoline Compound and Other Hiv Infection Therapeutic Agents
#160012′,3′-dideoxynucleoside analogues for the treatment or prevention of infections
#16002MELOXICAM FOR THE TREATMENT OF RESPIRATORY DISEASES IN PIGS
#16003Novel Use of Peptide Compounds For Treating Muscle Pain
#16004MODIFIED AMINO ACID FOR THE INHIBITION OF PLATELET AGGREGATION
#16005METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS
#16006Branched-chain amino acid composition for improving skeletal muscle protein metabolism
#16007Treatment of injury to the brain by inhibition of acid sensing ion channels
#16008PHYSIOLOGICALLY BALANCED, IONIZED, ACIDIC SOLUTION AND METHODOLOGY FOR USE IN WOUND HEALING
#16009TELOMERE TARGETING AGENTS AS STEM CELLS DIRECTED TREATMENTS
#16010Treatment of Asthma and Copd Using Triple-Combination Therapy
#16011Gold nanoparticles for selective IR heating
#16012EXTRACELLULAR MATRIX COMPOSITIONS FOR TISSUE REGENERATION
#16013Flurbiprofen and muscle relaxant combinations
#16014Use of Microtubule Stabilizing Compounds for the Treatment of Lesions of Cns Axons
#16015Use of salicylaldehyde isonicotinoyl hydrazone (SIH) for protection against retinal disease
#16016Delivery system and method to deliver homeopathic complexes comprising homeopathic colored pigment products for cosmetic use
#16017Topical formulation containing latex of fraction thereof, and cosmetic treatment method
#16018Ingestible Plaque Eliminator for Animals
#16019Ingestible Malodor Eliminator for Animals
#16020Phyto-nutraceutical synergistic composition for hyperlipedemic condition
#16021Therapy of Prostate Cancer With Ctla-4 Antibodies and Hormonal Therapy
#16022High throughput screen utilizing newly discovered intramolecular neuronal calcium channel interactions to discover new analgesics
#16023Combination therapy with co-stimulatory factors
#16024Treatment With Anti-VEGF Antibodies
#16025B-Cell Reduction Using CD37-Specific and CD20-Specific Binding Molecules
#16026Methods of treating lupus using CD4 antibodies
#16027COMBINATION THERAPY WITH A COMPOUND ACTING AS A PLATELET ADP RECEPTOR INHIBITOR
#16028Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency
#16029Composition for maintaining androgen and androgen-like uptake potential by cells
#16030OSTEOGENIC DIFFERENTIATION OF PREOSTEOBLASTIC CELLS
#16031SPONGY EPITHELIAL CELL SCAFFOLD FOR VASCULARIZING WOUNDS
#16032ARYLPIPERIDINYL AND ARYLPYRROLIDINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS
#16033Compositions and Methods for Treating Burns
#16034Combinations Therapy for Treatment of Demyelinating Conditions
#16035Combination Preparation of a Biological Response Modifier and an Anticancer Agent and Uses Thereof
#16036Treatment of Autoimmune Diseases and Allograft Rejection with IL-21
#16037METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#16038Cd4+ Cd25+ T-cells activated to a specific antigen
#16039Disease Prevention and Vaccination Prior to Thymic Reactivation
#16040Combination Of Dehydroepiandrosterone Or Dehydroepiandrosterone-Sulfate With An Anticholinergic Bronchodilator For Treatment Of Asthma Or Chronic Obstructive Pulmonary Disease
#16041Method for extending lifespan delaying the onset of age-related disease
#16042TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ANTI-PROLIFERATE AND ANTI-INFLAMMATORY DRUGS
#16043AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE
#16044ALIPHATIC ACID-CONTAINING N-HALOGENATED AMINO ACID FORMULATIONS
#16045Combination Composition
#16046N-HALOGENATED AMINO ACID FORMULATIONS
#16047N-HALOGENATED AMINO ACID FORMULATIONS WITH ANTI-INFLAMMATORY COMPOUNDS
#16048N-HALOGENATED AMINO ACID FORMULATIONS AND METHODS FOR CLEANING AND DISINFECTION
#16049LEUCINE RICH COMPOSITION
#16050Sesamin/Episesamin Compositions
#16051TOPICAL FORMULATIONS AND METHODS FOR ELIMINATION AND PROPHYLAXIS OF SUSCEPTIBLE AND TREATMENT RESISTANT STRAINS OF HEAD LICE WITH MULTIPLE MODES OF ACTION
#16052Combination of Prostaglandin E2 Receptor Antagonists and Renin-Angiotensin System Inhibitors for Treating Renal Diseases
#16053Compositions and methods to treat gastrointestinal disorders
#16054Methods for treating lower urinary tract disorders using alpha2delta subunit channel modulators with smooth muscle modulators
#16055Radiotherapy Enhancer
#16056PHARMACEUTICAL FORMULATION
#16057Formulation and Method for Treating Interstitial Cystitis and Related Bladder Conditions
#16058COMPOSITIONS AND METHODS TO PREVENT TOXICITY INDUCED BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS
#16059ORAL ADMINISTRATION OF N-(2-CHLORO-6-METHYLPHENYL)-2-[[6-[4-(2-HYDROXYETHYL)-1-PIPERAZINYL]-2-METHYL-4-PYRIMIDINYL]AMINO]-1,3-THIAZOLE-5-CARBOXAMIDE AND SALTS THEREOF
#16060CHARGED PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR USE
#16061Amelioration of the development of cataracts and other ophthalmic diseases
#16062Composition for restoration of age related tissue loss in the face or selected areas of the body
#16063ARTIFICIAL PHYSIOLOGICAL SALT SOLUTION AND MANUFACTURING METHOD FOR SAME
#16064COMPOSITION FOR TREATMENT OF COLD AND FLU
#16065Herbal extract for renal disorders
#16066Methods and compositions for controlling microorganism populations in the digestive system of animals
#16067METHODS OF TREATING INFLAMMATION
#16068Water treatment containing DBNPA for use in sanitizing recreational water
#16069ENA mineral bioactive solution, manufacturing method thereof and its application for the osteoporosis prevention
#16070Bioeffective krill oil compositions
#16071Organic Compounds Comprising a Glycopyrr Onium Salt
#16072Wound healing compositions containing keratin biomaterials
#16073Drug formulations for coating medical devices
#16074Cartilage implant plug with fibrin glue and method for implantation
#16075Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations
#16076Inhibition of Angiogenesis by Mithramycin
#16077Histone deacetylase (HDAC) inhibitors (PXD101) for the treatment of cancer alone or in combination with chemotherapeutic agent
#16078Use of opioid antagonists to attenuate endothelial cell proliferation and migration
#16079Tyrosine kinase inhibitors
#16080Molecular Complex Comprising Arbutine, Ascorbic Acid, Oleuropeina or Its Derivatives Thereof and Related Uses In Medical Field
#16081OXIMYL HYDROXYAMIC ANALOGS AS HEPATITIS C VIRUS PROTEASE INHIBITOR
#16082NOVEL USES
#16083Method for Treating Neurological Disorders
#16084EPINEPHRINE FORMULATIONS
#16085COMBINED USE OF EGF PATHWAY INHIBITORS AND DIFFERENTIATION PROMOTING COMPOUNDS
#16086Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events
#16087Magnesium compositions and uses thereof for cognitive function
#16088Therapeutic Combinations for the Treatment or Prevention of Depression
#16089Combination of Dpp-Iv Inhibitors and Compounds Modulating 5-Ht3 and/or 5-Ht4 Receptors
#16090Synergistic Combinations
#16091Use of the acetyl L-carnitine in association with the biotin for the treatment of patients with type 2 insulin-resistant diabetes mellitus
#16092TREATMENT METHOD
#16093Combination of Zd6474 and Pemetrexed
#16094Regulation of Autophagy and Cell Survival
#160951,2,4 oxadiazole compounds and methods of use thereof
#16096Benzodiazepine compositions for treating epidermal hyperplasia and related disorders
#16097Methods for avoiding edema in the treatment or prevention of PPARγ-responsive diseases, including cancer
#16098Method of treating cancers with SAHA and Pemetrexed
#16099Use of Megestrol Acetate for the Treatment of Obstructive Pulmonary Diseases
#16100Preparation Comprising Iron(III) Complex Compounds And Redox-Active Substance(s)
#16101Novel Medicaments for Anti-Retroviral Treatments
#16102Compositions and Methods Relating to Mitochondrial Hyperpolarization in Neurological Disease
#16103Preparation for use of aspartate for regulating glucose levels in blood
#16104Method of treating dyslipidemic disorder
#16105Method of supplementing an edible aqueous liquid composition with two or more mineral salts
#16106Capsaicin Nutritional Supplement
#16107Herbal composition weight management
#16108Sparc Promoter Mutations Associated with Drug Resistance, and Methods, Oligonucleotides, Cells and Arrays Associated Therewith
#16109Methods and Compositions for Treating Thalamocortical Dysrhythmia
#16110Synergistic Formulation for Preventing and/or Treating Diabetes
#16111METHOD FOR TREATING CARTILAGE DEFECTS
#16112Stable Solid Dosage Forms of Amlodipine and Benazepril
#16113PHARMACEUTICAL COMPOSITION FOR CONTRACEPTION AND FOR REDUCING THE RISK OF CONGENITAL ABNORMALITIES
#16114Formulations with Controlled Release of Active Ingredient
#16115Controlled Release Compositions Comprising an Antipsychotic Agent
#16116OMEGA 3 FATTY ACID FORMULATIONS
#16117COMBINATION OF PROGESTERONE-RECEPTOR ANTAGONIST TOGETHER WITH NONE-STEROIDAL ANTIESTROGEN FOR USE IN BRCA MEDIATED DISEASES
#16118Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength
#16119Compositions for Oral and/or Topical Administration
#16120Activating extraction of demineralized bone matrix
#16121Probiotic strains for improved vaginal health
#16122Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
#16123Combined immunological agent and sensitizing agent for the treatment of cancer
#16124TREATMENT WITH ANTI-VEGF ANTIBODIES
#16125Synergistic Effect of Tgf-Beta Blockade and Immunogenic Agents on Tumors
#16126Methods of treating neoplastic, autoimmune and inflammatory diseases
#16127Combination cancer therapy
#16128SYNERGISTIC ANTI-HYPERTENSIVE PHYTO-NUTRACEUTICAL COMPOSITION
#16129CARDIAC PHYTO-NUTRACEUTICAL SYNERGISTIC COMPOSITION
#16130AraC in combination with a cytokine-secreting cell and methods of use thereof
#16131Methods for improving cell therapy and tissue regeneration in patients with cardiovascular diseases by means of shockwaves
#16132HAIR UNDIFFERENTIATED CELLS
#16133Quinoxalinyl dipeptide hepatitis C virus inhibitors
#16134N-FUNCTIONALIZED AMIDES AS HEPATITIS C SERINE PROTEASE INHIBITORS
#16135Cyclic P3 tripeptide hepatitis C serine protease inhibitors
#16136Hcv Ns3-Ns4a Protease Inhibition
#16137Methods and Compositions Using Selective Cytokine Inhibitory Drugs for Treatment and Management of Cancers and Other Diseases
#16138Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists
#16139METHOD OF TREATING CANCER
#16140ENHANCED WOUND HEALING
#16141DYNAMIC NERVE STIMULATION IN COMBINATION WITH OTHER EATING DISORDER TREATMENT MODALITIES
#16142Treatment of Comorbid Premature Ejaculation and Erectile Dysfunction
#16143Infiltration of capsaicin into surgical sites and open wounds
#16144Novel Use of Nutraceutical Compositions Comprising Resveratrol
#16145PHARMACEUTICAL FORMULATIONS CONTAINING LIPOIC ACID DERIVATIVES
#16146Compositions And Kits Comprising A Melatonin Component And A Flavanol Component
#16147Methods of treatment and pharmaceutical composition
#16148Ppar-Gamma Agonists for Improvement of Cognitive Function in Apoe4 Negative Patients
#16149Methods for treating neoplasia with combination of chemotherapeutic agents and radiation
#16150Use of S-adenosylmethionine, vitamin E, and vitamin C for the treatment of oxidative liver injury and insulin resistance
#16151Reducing Side Effects of Tramadol
#16152Combination of Organic Compounds
#16153Use of Pharmaceutical Compositions of Lofepramine for the Treatment of Adhd, Cfs, Fm and Depression
#16154COMBINATIONS OF BILE ACID SEQUESTRANT(S) AND STEROL ABSORPTION INHIBITOR(S) AND TREATMENTS FOR VASCULAR INDICATIONS
#16155Dosage form for hormonal contraception
#16156COMBINATION OF PROGESTERONE-RECEPTOR ANTAGONIST TOGETHER WITH A LUTEIN-HORMONE-RELEASING HORMONE AGONIST AND ANTAGONIST FOR USE IN BRCA MEDIATED DISEASES
#16157METHODS AND COMPOSITIONS FOR THE PREVENTION AND/OR TREATMENT OF AN EXACERBATION OF ASTHMA
#16158Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application
#16159Method of treating human preeclampsia employing resibufagenin
#16160Stable Aqueous Suspension
#16161Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists
#16162Formulation Containing a Polyphenol-Containing Composition and Isomaltulose
#16163Combination Therapy with Glatiramer Acetate and Rasagiline for the Treatment of Multiple Sclerosis
#16164TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING
#16165COMPOSITIONS AND METHODS FOR USING SYRINGOPEPTIN 25A AND RHAMNOLIPIDS
#16166Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
#16167Single-dose administration of Factor VIIa
#16168Lung volume reduction therapy using crosslinked biopolymers
#16169Method of inducing and maintaining neuronal cells
#16170Compositions Comprising Glycosaminoglycan and Nonsteroidal Anti-Inflammatory Drug
#16171Combination of nateglinide or repaglinide with at least one further antidiabetic compound
#16172Blue-green algae composition
#16173Plant extracts and compositions for reducing blood lipid levels
#16174Garlic Extract Compositions, Uses And Preparations Thereof
#16175Skin care compositions and methods
#16176Folate based composition for neurological and cognitive applications
#16177Composition Containing Omega-3 Fatty Acids and Omega-6 Fatty Acids
#16178Universal Procoagulant
#16179Topical composition containing sacred water
#16180MULTIPLE ACTIVE DRUG RESIN CONJUGATE
#16181Physically stable aqueous suspensions of active pharmaceuticals
#16182Methods and compositions for reduction of side effects of therapeutic treatments
#16183Oral dosage formulations of protease-resistant polypeptides
#16184Compositions for the Treatment of Inflammation and Pain Using a Combination of a Cox-2 Selective Inhibitor and a Ltb4 Receptor Antagonist
#16185Injectable capsaicin
#16186Plasmid Enhancement Agent for High Intensity Focused Ultrasound Treatment and Use Thereof
#16187Use of Collagen in Combination With Oxygen- and Ozone-Releasing Perfluorocarbons For the Preparation of a Medicament For the Treatment of Skin Lesions
#16188Compositions and methods for modulating an immune response
#16189PROSTATE DISORDER(S) PHYTO-NUTRACEUTICAL SYNERGISTIC COMPOSITION
#16190Peptide inhibitors of IASPP
#16191Targeted identification of immunogenic peptides
#16192Combination of BLyS and/or APRIL inhibition and immunosuppressants for treatment of autoimmune disease
#16193Treatment of Severe Multiple Sclerosis
#16194Fibrin Compositions Containing Strontium Compounds
#16195Method for suppressing surgical site infection and column to be used for the method
#16196METHODS AND RELATED SYSTEMS AND FORMULATIONS TO NORMALIZE AND IMPROVE HUMAN BODY CHEMISTRY AND HEALING ABILITY
#16197Combination treatment of cardiovascular disease
#16198Treatment of Insulin Resistance and Diabetes
#16199Composition for prevention and/or treatment of cancer
#16200Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof